article thumbnail

Influencing Factors of Adherence Dynamics in Young Adults with Hypertension: A Mixed-Methods Study [Hypertension]

Annals of Family Medicine

Context Young adults with hypertension are a susceptible group prone to changes in adherence influenced by external factors, which are associated with lower control rates and adverse long-term prognoses. However, the factors influencing the dynamics of adherence among young Chinese patients with hypertension remain unclear.

article thumbnail

Evaluating the Impact of Data Visualization with China-PAR on Hypertension Management in Primary Care: A Pilot Study [Hypertension]

Annals of Family Medicine

Although data visualization is gaining traction in the hypertension, its use in health education and information dissemination is still underutilized. Objective This study aims to investigate the impact of data visualization using China-PAR on managing hypertension among primary care patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Population Studied individuals with comorbidity of hypertension and type 2 diabetes. Outcome Measures Changes of China-PAR score and cardiovascular hospitalization events.

article thumbnail

“The physician–patient encounter is health care’s choke point” -NEJM

A Country Doctor Writes

Its basic argument was that it isn’t sustainable to only see patients one by one in traditional doctor visits. I thought of it the other day when I put together a presentation about Galileo’s way of interacting with patients. The physician–patient encounter is health care’s choke point.

Patients 130
article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. and worldwide,” Paul Whelton, M.D., All rights reserved.

article thumbnail

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Objectives To assess overall medication adherence as an indicator for emergency room (ER) visits, hospitalizations, and mortality among elderly patients. We retrieved information on all ER visits and hospitalizations in internal medicine and surgical wards from 2017 to 2019 and mortality in 2019. The mean age was 81.2

article thumbnail

Intensity of medication review activities in private and public clinics [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

Setting: One private primary care clinic and two clinics of a safety net hospital system that serves inner-city populations with significant socio-economic challenges. Population: Primary care visits by patients 55 years or older, taking 5 or more chronic medications, speaking English or Spanish during April through December 2023.

Clinic 130